Arca Biopharma | ABIO - Market Capitalization


Arca Biopharma reported $960.6M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alterity Therapeutics Limited AUD 40M 16M May/2026
Amgen USD 189.89B 13.64B Mar/2026
Arca Biopharma USD 1.47B 537M Dec/2025
Biogen USD 26.9B 1.09B Mar/2026
Brainstorm Cell Therapeutics USD 8M 3M Sep/2025
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Cipla INR 1.22T 6.47B Dec/2025
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 144.67M 7.17M Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Cytokinetics USD 9.25B 1.48B May/2026
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Laboratory Of America USD 21.93B 1.13B Mar/2026
Myriad Genetics USD 575M 98M Dec/2025
Otsuka Holdings JPY 5.98T 1.16T Mar/2026
Pfizer USD 148.08B 6.51B May/2026
United Therapeutics USD 20.98B 2.02B Dec/2025